Global Pets Anti-infective Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Pets Anti-infective Drugs market size was valued at US$ 1833 million in 2024 and is forecast to a readjusted size of USD 5451 million by 2031 with a CAGR of 16.6% during review period.

Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.

The pet anti-infective drug market is a growing area. With the expansion of the global pet market and the improvement of pet health awareness, this market has shown great development potential.

The pet anti-infective drug market is dominated by many well-known companies, such as Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products and Ceva Santé Animale, which have deep technical accumulation and market experience in veterinary drug research and development, production and market operation.

The market concentration is high, and a few companies occupy a large market share, but with the entry of new companies and the intensification of market competition, the market pattern may change.

Pet anti-infective drugs mainly include antibiotics, antibacterial drugs and other types, which are used to prevent and treat various bacterial infections of pets. These drugs play an important role in improving the quality of life of pets and prolonging their lifespan.

With the advancement of science and technology and the increase in R&D investment, new products and new therapies will continue to emerge in the pet anti-infective drug market. These innovative products will have better efficacy, lower side effects and higher safety, meeting the diverse needs of pet owners.

With the development of precision medicine, the pet anti-infective drug market will pay more attention to personalized treatment in the future. Providing customized anti-infection treatment plans for pets of different types, ages, and health conditions will become an important direction for market development.

This report is a detailed and comprehensive analysis for global Pets Anti-infective Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Administration Method and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Pets Anti-infective Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Pets Anti-infective Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Pets Anti-infective Drugs market size and forecasts, by Administration Method and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Pets Anti-infective Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Pets Anti-infective Drugs

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Pets Anti-infective Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva Santé Animale, Vetoquinol, Nanjing Jindun Animal, Wuhan Chopperlvya, Bimeda Animal Health, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Pets Anti-infective Drugs market is split by Administration Method and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Administration Method, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Administration Method
External Use
Internal Use
Injection

Market segment by Application
Dog
Cat
Others

Major players covered
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Santé Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook
Hanvet Pet Health
Wuhan Hvsen Biotechnology
Zhejiang Hisun Animal Healthcare Products

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pets Anti-infective Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Pets Anti-infective Drugs, with price, sales quantity, revenue, and global market share of Pets Anti-infective Drugs from 2020 to 2025.

Chapter 3, the Pets Anti-infective Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pets Anti-infective Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Administration Method and by Application, with sales market share and growth rate by Administration Method, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pets Anti-infective Drugs market forecast, by regions, by Administration Method, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Pets Anti-infective Drugs.

Chapter 14 and 15, to describe Pets Anti-infective Drugs sales channel, distributors, customers, research findings and conclusion.